Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature

K. Murray, L. Kun, J. Cox

Research output: Contribution to journalArticle

231 Citations (Scopus)

Abstract

Eleven patients with primary malignant lymphoma of the central nervous system (CNS) were treated at the Medical College of Wisconsin Affiliated Hospitals between 1964 and 1984. Three patients had a prior history of immunosuppressive therapy following renal transplantation. All patients had biopsy-proven disease and 10 of the 11 were treated with external radiation therapy. The doses to the primary tumor ranged from 34 to 59.4 Gray (Gy). Actuarial (life-table) survival rate was 82% at 1 year and 43% at 3 years. No recurrence was seen after 13 months. Eighty-six reports totaling 693 cases of primary malignant lymphoma of the CNS were found in the literature. Of these, 308 cases were treated with a combination of surgery and irradiation. Overall survival at 5 years for those patients who received more than 50 Gy compared with less than 50 Gy to the primary tumor was 42.3% versus 12.8% (p < 0.05). Twenty-one patients survived longer than 5 years. Late relapse was notable, with 10 (47.6%) of 21 tumors recurring between 5 and 12.5 years after diagnosis. Based on this review, a minimum of 50 Gy radiation to the primary tumor is recommended. While no statement regarding the efficacy of craniospinal irradiation or chemotherapy can be made in view of the small numbers, the use of craniospinal irradiation and/or systemic chemotherapy should be considered for future trials.

Original languageEnglish (US)
Pages (from-to)600-607
Number of pages8
JournalJournal of Neurosurgery
Volume65
Issue number5
DOIs
StatePublished - Jan 1 1986

Fingerprint

Lymphoma
Central Nervous System
Craniospinal Irradiation
Neoplasms
Therapeutics
Recurrence
Drug Therapy
Life Tables
Immunosuppressive Agents
Kidney Transplantation
Radiotherapy
Survival Rate
Radiation
Biopsy
Survival

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature. / Murray, K.; Kun, L.; Cox, J.

In: Journal of Neurosurgery, Vol. 65, No. 5, 01.01.1986, p. 600-607.

Research output: Contribution to journalArticle

@article{9142dc2800d94fefb398f543ad285ff6,
title = "Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature",
abstract = "Eleven patients with primary malignant lymphoma of the central nervous system (CNS) were treated at the Medical College of Wisconsin Affiliated Hospitals between 1964 and 1984. Three patients had a prior history of immunosuppressive therapy following renal transplantation. All patients had biopsy-proven disease and 10 of the 11 were treated with external radiation therapy. The doses to the primary tumor ranged from 34 to 59.4 Gray (Gy). Actuarial (life-table) survival rate was 82{\%} at 1 year and 43{\%} at 3 years. No recurrence was seen after 13 months. Eighty-six reports totaling 693 cases of primary malignant lymphoma of the CNS were found in the literature. Of these, 308 cases were treated with a combination of surgery and irradiation. Overall survival at 5 years for those patients who received more than 50 Gy compared with less than 50 Gy to the primary tumor was 42.3{\%} versus 12.8{\%} (p < 0.05). Twenty-one patients survived longer than 5 years. Late relapse was notable, with 10 (47.6{\%}) of 21 tumors recurring between 5 and 12.5 years after diagnosis. Based on this review, a minimum of 50 Gy radiation to the primary tumor is recommended. While no statement regarding the efficacy of craniospinal irradiation or chemotherapy can be made in view of the small numbers, the use of craniospinal irradiation and/or systemic chemotherapy should be considered for future trials.",
author = "K. Murray and L. Kun and J. Cox",
year = "1986",
month = "1",
day = "1",
doi = "10.3171/jns.1986.65.5.0600",
language = "English (US)",
volume = "65",
pages = "600--607",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "5",

}

TY - JOUR

T1 - Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature

AU - Murray, K.

AU - Kun, L.

AU - Cox, J.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - Eleven patients with primary malignant lymphoma of the central nervous system (CNS) were treated at the Medical College of Wisconsin Affiliated Hospitals between 1964 and 1984. Three patients had a prior history of immunosuppressive therapy following renal transplantation. All patients had biopsy-proven disease and 10 of the 11 were treated with external radiation therapy. The doses to the primary tumor ranged from 34 to 59.4 Gray (Gy). Actuarial (life-table) survival rate was 82% at 1 year and 43% at 3 years. No recurrence was seen after 13 months. Eighty-six reports totaling 693 cases of primary malignant lymphoma of the CNS were found in the literature. Of these, 308 cases were treated with a combination of surgery and irradiation. Overall survival at 5 years for those patients who received more than 50 Gy compared with less than 50 Gy to the primary tumor was 42.3% versus 12.8% (p < 0.05). Twenty-one patients survived longer than 5 years. Late relapse was notable, with 10 (47.6%) of 21 tumors recurring between 5 and 12.5 years after diagnosis. Based on this review, a minimum of 50 Gy radiation to the primary tumor is recommended. While no statement regarding the efficacy of craniospinal irradiation or chemotherapy can be made in view of the small numbers, the use of craniospinal irradiation and/or systemic chemotherapy should be considered for future trials.

AB - Eleven patients with primary malignant lymphoma of the central nervous system (CNS) were treated at the Medical College of Wisconsin Affiliated Hospitals between 1964 and 1984. Three patients had a prior history of immunosuppressive therapy following renal transplantation. All patients had biopsy-proven disease and 10 of the 11 were treated with external radiation therapy. The doses to the primary tumor ranged from 34 to 59.4 Gray (Gy). Actuarial (life-table) survival rate was 82% at 1 year and 43% at 3 years. No recurrence was seen after 13 months. Eighty-six reports totaling 693 cases of primary malignant lymphoma of the CNS were found in the literature. Of these, 308 cases were treated with a combination of surgery and irradiation. Overall survival at 5 years for those patients who received more than 50 Gy compared with less than 50 Gy to the primary tumor was 42.3% versus 12.8% (p < 0.05). Twenty-one patients survived longer than 5 years. Late relapse was notable, with 10 (47.6%) of 21 tumors recurring between 5 and 12.5 years after diagnosis. Based on this review, a minimum of 50 Gy radiation to the primary tumor is recommended. While no statement regarding the efficacy of craniospinal irradiation or chemotherapy can be made in view of the small numbers, the use of craniospinal irradiation and/or systemic chemotherapy should be considered for future trials.

UR - http://www.scopus.com/inward/record.url?scp=0022978906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022978906&partnerID=8YFLogxK

U2 - 10.3171/jns.1986.65.5.0600

DO - 10.3171/jns.1986.65.5.0600

M3 - Article

C2 - 3772445

AN - SCOPUS:0022978906

VL - 65

SP - 600

EP - 607

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 5

ER -